AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Is Biotech a Cash Burning Machine?
There's 800 biotech companies that have less than two years of cash, 150 of them have negative enterprise value. When capital is abundant, every experiment gets tried and then when the proverbial stuff hits the fan, people are giving up their equity in those companies. I think the most likely trend here is a combination of investors forcing at a board level roll ups combinations where people have redundant efforts.